Would you offer adjuvant abemaciclib to young, premenopausal women desiring more children who meet criteria for the same based on monarchE trial?
Is there data on the long-term effects of abemaciclib on future fertility and pregnancy after its discontinuation?
Does patient's desire for future pregnancy factor into your decision-making regarding eligibility for abemaciclib?